Qing Sheng
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
Papers in
-
- Histone Deacetylase Inhibitors Research 6
- RNA Research and Splicing 5
- Studies on Chitinases and Chitosanases 5
- Ubiquitin and proteasome pathways 5
- Oncology 21
- HER2/EGFR in Cancer Research 8
- Co-authors
- David M. Livingston (3 shared papers)Bing Xia (2 shared papers)Xinggang Liu (2 shared papers)Jun S. Liu (1 shared paper)Koji Nakanishi (1 shared paper)Fergus J. Couch (1 shared paper)Maria Jasin (1 shared paper)Akihiro Ohashi (1 shared paper)
- Journals
- Cancer Research (7 papers)Applied Biochemistry and Biotechnology (4 papers)British Journal of Cancer (3 papers)Archives of Insect Biochemistry and Physiology (3 papers)BMC Genomics (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Qing Sheng
77 papers receiving 2.7k citations
Qing Sheng's Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 610
- Oncology 824
- Molecular Biology 1.8k
- Genetics 571
- Reproductive Medicine 116
Countries citing papers authored by Qing Sheng
This map shows the geographic impact of Qing Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Sheng more than expected).
Fields of papers citing papers by Qing Sheng
This network shows the impact of papers produced by Qing Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Sheng. The network helps show where Qing Sheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Qing Sheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2 Hit paper breakdown → | 2006 | 635 |
| 2 | 2006 | 348 | |
| 3 | 2010 | 178 | |
| 4 | 2011 | 142 | |
| 5 | 2014 | 140 | |
| 6 | 2014 | 77 | |
| 7 | 1997 | 76 | |
| 8 | 2013 | 72 | |
| 9 | 2011 | 66 | |
| 10 | 2008 | 62 | |
| 11 | 2010 | 55 | |
| 12 | 2007 | 54 | |
| 13 | 2013 | 46 | |
| 14 | 2013 | 46 | |
| 15 | 2015 | 44 | |
| 16 | 2019 | 43 | |
| 17 | 2020 | 42 | |
| 18 | 2010 | 36 | |
| 19 | 2013 | 35 | |
| 20 | 2015 | 29 |
About Qing Sheng
Qing Sheng is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Plant Science and Cancer Research, having authored 79 papers that have together received 2.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Silk-based biomaterials and applications (7 papers), Histone Deacetylase Inhibitors Research (6 papers), MicroRNA in disease regulation (6 papers), RNA Research and Splicing (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Studies on Chitinases and Chitosanases (5 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Cancer Research (610 citations), Oncology (824 citations), Molecular Biology (1.8k citations), Genetics (571 citations) and Reproductive Medicine (116 citations). Qing Sheng has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include David M. Livingston, Bing Xia, Xinggang Liu, Jun S. Liu, Koji Nakanishi, Fergus J. Couch, Maria Jasin, Akihiro Ohashi, Nicole Christ and Jianmin Wu. Their work appears in journals such as Cancer Research, Applied Biochemistry and Biotechnology, British Journal of Cancer, Archives of Insect Biochemistry and Physiology and BMC Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.